New York, United States
Coridea is a medical device incubator specializing in cardiac, pulmonary, and renal innovation. Founded in 2003, it is driven by an innovative and translational healthcare approach. Coridea develops unexpected device solutions that positively impact the lives of patients in these fields where no other treatment options exist.
The company has a strong track record of inventing innovative technology and translating it into high-impact solutions for patients, as well as delivering high value returns for investors. The success is evident in the launch of six cardiology and renal-focused companies in the past decade, with a goal to expand the portfolio by launching a new company every two years. Coridea's last investment of $853.76K in debt financing was made on 07 June 2012.
With its focus on the healthcare and medical devices industries, Coridea presents an enticing opportunity for investors seeking to support valuable innovation and make a meaningful impact in patient care and treatment options.
